Neurogene Inc.
Neurogene Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative gene therapies for rare neurological disorders. Founded in 2019, Neurogene has quickly established itself as a leader in the field, leveraging advanced gene delivery technologies to address unmet medical needs. The company’s core offerings include cutting-edge gene therapies designed to target specific genetic mutations, setting them apart in the competitive landscape of gene therapy. With a commitment to transforming the lives of patients and their families, Neurogene has achieved significant milestones, including collaborations with leading research institutions and advancements in clinical trials. As it continues to expand its operational reach, Neurogene remains dedicated to pushing the boundaries of science to provide hope for those affected by debilitating neurological conditions.
DitchCarbon Score
How does Neurogene Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Neurogene Inc.'s score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Neurogene Inc.'s reported carbon emissions
Neurogene Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or commitments outlined in their sustainability initiatives. Without specific emissions figures or reduction goals, it is challenging to assess their climate impact or commitments in detail. However, the absence of data may indicate an opportunity for the company to enhance transparency and establish measurable climate objectives in line with industry standards. As the focus on corporate sustainability intensifies, Neurogene Inc. may consider developing a comprehensive strategy to address carbon emissions and contribute positively to climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Neurogene Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
